3-(Pyridin-2-yl)-1,2,4-thiadiazol-5-amine, 95.0%, 100mg

[1,1'-Biphenyl]-3,3'-diyldimethanamine, 95%, 1g

H-Thr(tBu)-OH, 95.0%, 1g

dimethyl sulfoxide D6, 99.8 at%D, 100 ml, glass packaging

(3R,4R)-4-fluoro-3-pyrrolidinol hydrochloride, 95.0%, 1g

3,5-Dibromo-4-fluoroaniline, 95.0%, 1g

ETHYL 4-BROMOQUINOLINE-6-CARBOXYLATE, 95.0%, 250mg

1-N-Cbz-3-Piperidone, 97.0%, 100g

Boric acid, min. 99.8%, pa, ACS, ISO, 2.5 kg, plastic packaging.

(5-METHYL-1,2,4-OXADIAZOL-3-YL)ACETIC ACID, 95.0%, 250mg

Ethyl 3-(chloromethyl)benzoate, 95.0%, 25g

4-[(3-fluorophenyl)methyl]piperidine hydrochloride, 95.0%, 100mg

5-Bromo-3-(2,2,2-trifluoroethoxy)pyrazin-2-amine, 95.0%, 5g